MYADM has been implicated in atherosclerotic disease and hypertension as a target of miR-182 [61,62,63], which was previously found to modulate human smooth muscle cell differentiation, proliferation, and migration [63]. This evidence concerns the gene MYADM and hypertensive disorder.